Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Co-Diagnostics (CODX) Misses Q3 EPS by 10c
November 10, 2022 4:16 PM ESTCo-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More